Omeat
Kenneth Delgado currently serves as the VP, Controller at Omeat, overseeing financial operations in biotechnology research, development, and manufacturing since January 2023. Prior to this role, Kenneth held the position of Senior Financial & Budget Analyst at Vancouver Clinic, where responsibilities involved financial analysis for multi-specialty healthcare clinics from January 2021 to January 2023. Kenneth's prior experience includes serving as VP of Finance & Administration at Lensbaby, Controller at VoIP Guardian, Accounting Manager at Prospect Mortgage, Senior Accountant at GGW Brands, Staff Accountant at BioTAB Healthcare, and Staff Accountant at Hankey Group of Companies. Kenneth holds a Bachelor's Degree in Business Economics with a focus on Finance from the University of California, Riverside, completed in 2007.
This person is not in any teams
Omeat
Omeat is a food startup that has pioneered a scalable way to produce cultivated meat that’s delicious, affordable, orders-of-magnitude more sustainable than conventional meat, and doesn’t involve sacrificing an animal. The secret to Omeat is a proprietary process that harnesses the intrinsically regenerative factors within cows' plasma to foster cell growth. Omeat’s growth media is a cost-effective alternative to fetal bovine serum and can be used to cultivate any kind of meat. Omeat is based in Los Angeles, founded in 2020 by world-renown tissue biologist Dr. Ali Khademhosseini. The company is currently building a pilot plant and rapidly expanding its team toward commercial readiness.